REFERENCE LIST

 

    1. Acne: Oláh, A., Markovics, A., Szabó-Papp, J., Szabó, P.T., Stott, C., Zouboulis, C.C. and Bíró, T. (2016). Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Experimental Dermatology, [online] 25(9), pp.701–707. 
    2. Nausea: Parker, L.A., Rock, E.M. and Limebeer, C.L. (2011). Regulation of nausea and vomiting by cannabinoids. British Journal of Pharmacology, [online] 163(7), pp.1411–1422.
    3. Sleep: Chagas, M.H.N., Crippa, J.A.S., Zuardi, A.W., Hallak, J.E.C., Machado-de-Sousa, J.P., Hirotsu, C., Maia, L., Tufik, S. and Andersen, M.L. (2013). Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of Psychopharmacology, 27(3), pp.312–316. 
    4. Anxiety: Bergamaschi, M.M., Queiroz, R.H.C., Chagas, M.H.N., de Oliveira, D.C.G., De Martinis, B.S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A.E., Martín-Santos, R., Hallak, J.E.C., Zuardi, A.W. and Crippa, J.A.S. (2011). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. Neuropsychopharmacology, [online] 36(6), pp.1219–1226.
    5. Chronic pain: Schilling, J.M., Hughes, C.G., Wallace, M.S., Sexton, M., Backonja, M. and Moeller-Bertram, T. (2021). Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes. Journal of Pain Research, Volume 14, pp.1241–1250. 
    6. Arthritis/joints: Frane, N., Stapleton, E., Iturriaga, C., Ganz, M., Rasquinha, V. and Duarte, R. (2022). Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. Journal of Cannabis Research, 4(1). 
    7. PMS: Ashton, L. (2020). CBD Oil for Menstrual Cramps: Does Cannabis Help with PMS? [online] CFAH. Available at: https://cfah.org/cbd-for-menstrual-cramps/ 
    8. Headaches: Cuttler, C., Spradlin, A., Cleveland, M.J. and Craft, R.M. (2019). Short- and Long-Term Effects of Cannabis on Headache and Migraine. The Journal of Pain. [online] 
    9. Recovery, sleep, pain: Moltke, J. and Hindocha, C. (2021). Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. Journal of Cannabis Research, 3(1). 
    10. PTSD Anxiety: Bitencourt, R.M. and Tekahashi, R.N. (2018). Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials. [online] frontiers. Available at: https://www.frontiersin.org/articles/10.3389/fnins.2018.00502/full?_ga=2.28443646.376123967.1620850395-746040275.1604383068.
    11. Asthma: Vuolo, F., Abreu, S.C., Michels, M., Xisto, D.G., Blanco, N.G., Hallak, J.E., Zuardi, A.W., Crippa, J.A., Reis, C., Bahl, M., Pizzichinni, E., Maurici, R., Pizzichinni, M.M.M., Rocco, P.R.M. and Dal-Pizzol, F. (2019). Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, 843, pp.251–259. 
    12. Epilepsy: Pamplona, F.A., Silva, L.R. da and Coan, A.C. (2018). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. [online] frontiers.
    13. MS: Sastre-Garriga, J., Vila, C., Clissold, S. and Montalban, X. (2011). THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. Expert Review of Neurotherapeutics, 11(5), pp.627–637. 
    14. Lung conditions: Muthumalage, T. and Rahman, I. (2019). Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts. Toxicology and Applied Pharmacology, 382, p.114713.
    15. Anxiety and Sleep: Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm J. 2019;23:18-041. doi:10.7812/TPP/18-041
    16. Inflammation and Neuropathic pain: Xiong W, Cui T, Cheng K, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. J Exp Med. 2012;209(6):1121-1134. doi:10.1084/jem.20120242
    17. CBD and Sports Performance: McCartney D, Benson MJ, Desbrow B, Irwin C, Suraev A, McGregor IS. Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research. Sports Med Open. 2020;6(1):27. Published 2020 Jul 6. doi:10.1186/s40798-020-00251-0
    18. CBD on Acne: Peyravian N, Deo S, Daunert S, Jimenez JJ. The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne. J Inflamm Res. 2022;15:2795-2801. Published 2022 May 3. doi:10.2147/JIR.S355489
    19. Neurodegenerative Disorders: Fernández-Ruiz J, Sagredo O, Pazos MR, et al. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?. Br J Clin Pharmacol. 2013;75(2):323-333. doi:10.1111/j.1365-2125.2012.04341.x
    20. Topical CBD Use: Xu DH, Cullen BD, Tang M, Fang Y. The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. Curr Pharm Biotechnol. 2020;21(5):390-402. doi:10.2174/1389201020666191202111534
    21. Use of Essential Oils Topically: de Cássia da Silveira E Sá R, Lima TC, da Nóbrega FR, de Brito AEM, de Sousa DP. Analgesic-Like Activity of Essential Oil Constituents: An Update. Int J Mol Sci. 2017;18(12):2392. Published 2017 Dec 9. doi:10.3390/ijms18122392